Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
24-Hour FEV1 Profile of QMF Twisthaler in Persistent Asthma
NCT00557440Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of indacaterol + mometasone furoate in asthma, sponsored by Novartis. Started Nov 2007; status: completed.
02
Drugs
indacaterol + mometasone furoate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00557440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00557440.